In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Dimercaprol showed promise in murine models as an SVMP inhibitor against Echis ocellatus venom (115); however, it lacked this protective effect in vivo against Dispholidus typus venom (60), likely due to the high levels of divergence in venom composition between these distantly related species.”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [60]
In the citing paper
“the SVMP inhibitor prinomastat and the metal chelator dimercaprol showed moderate to high SVMP inhibitory activity in vitro but failed to confer any protection towards crude venom in in vivo assays (60).”
From Assessing Target Specificity of the Small Molecule Inhibitor MARIMASTAT to Snake Venom Toxins: A Novel Application of Thermal Proteome Profiling (2024) · cites this paper as [60]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Xie, C., Albulescu, L.-O., Still, K. B. M., Slagboom, J., Zhao, Y., Jiang, Z., Somsen, G. W., Vonk, F. J., Casewell, N. R., & Kool, J. (2020) · Biomedicines · doi:10.3390/biomedicines8060165 · Cited by 58
Self-citation
Research works printed but not linked: 51
- Ainsworth, 2018, The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms, Commun. Biol., 1, 1, 10.1038/s42003-018-0039-1 · DOI
- Albulescu, 2020, Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite, Sci. Transl. Med., 12, 10.1126/scitranslmed.aay8314 · DOI · Paper page
- Albulescu, 2020, A therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite, Nat. Commun., 11, 6094, 10.1038/s41467-020-19981-6 · DOI · Paper page
- Alomran, 2021, Pathology-specific experimental antivenoms for haemotoxic snakebite: the impact of immunogen diversity on the in vitro cross-reactivity and in vivo neutralisation of geographically diverse snake venoms, PLoS Negl. Trop. Dis., 15, 10.1371/journal.pntd.0009659 · DOI
- Arias, 2017, Peptidomimetic hydroxamate metalloproteinase inhibitors abrogate local and systemic toxicity induced by Echis ocellatus (saw-scaled) snake venom, Toxicon Off. J. Int. Soc. Toxinol., 132, 40, 10.1016/j.toxicon.2017.04.001 · DOI · Paper page
- Berling, 2015, Hematologic effects and complications of snake envenoming, Transfus. Med. Rev., 29, 82, 10.1016/j.tmrv.2014.09.005 · DOI · Paper page
- Bittenbinder, 2018, Coagulotoxic cobras: clinical implications of strong anticoagulant actions of African spitting Naja venoms that are not neutralised by antivenom but are by LY315920 (varespladib), Toxins, 10, 516, 10.3390/toxins10120516 · DOI · Paper page
- Bryan-Quirós, 2019, Neutralizing properties of LY315920 toward snake venom group I and II myotoxic phospholipases A2, Toxicon, 157, 1, 10.1016/j.toxicon.2018.11.292 · DOI · Paper page
- Bulfone, 2018, Developing small molecule therapeutics for the initial and adjunctive treatment of snakebite, J. Trop. Med., 2018, 1, 10.1155/2018/4320175 · DOI · Paper page
- Casewell, 2010, Pre-clinical assays predict Pan-African Echis viper efficacy for a species-specific antivenom, PLoS Negl. Trop. Dis., 4, 10.1371/journal.pntd.0000851 · DOI · Paper page
- Chowdhury, 2021, Venom-induced blood disturbances by palearctic viperid snakes, and their relative neutralization by antivenoms and enzyme-inhibitors, Front. Immunol., 12, 688802, 10.3389/fimmu.2021.688802 · DOI
- Chowdhury, 2021, The relative efficacy of chemically diverse small-molecule enzyme-inhibitors against anticoagulant activities of African spitting cobra (Naja species) venoms, Front. Immunol., 12, 10.3389/fimmu.2021.752442 · DOI · Paper page
- Clare, 2021, Small molecule drug discovery for neglected tropical snakebite, Trends Pharmacol. Sci., 42, 340, 10.1016/j.tips.2021.02.005 · DOI · Paper page
- de Silva, 2016, Adverse reactions to snake antivenom, and their prevention and treatment, Br. J. Clin. Pharmacol., 81, 446, 10.1111/bcp.12739 · DOI · Paper page
- Debono, 2017, Coagulating colubrids: evolutionary, pathophysiological and biodiscovery implications of venom variations between boomslang (Dispholidus typus) and twig snake (Thelotornis mossambicanus), Toxins, 9, 171, 10.3390/toxins9050171 · doi:10.3390/toxins9050171
- Debono, 2020, The sweet side of venom: glycosylated prothrombin activating metalloproteases from Dispholidus typus (boomslang) and Thelotornis mossambicanus (twig snake), Comp. Biochem. Physiol. C Toxicol. Pharmacol., 227, 108625, 10.1016/j.cbpc.2019.108625 · DOI
- Gomperts, 1977, Laboratory studies and clinical features in a case of boomslang envenomation, South Afr. Med. J. Suid-Afr Tydskr Vir Geneeskd., 51, 173
- Gutiérrez, 2006, Confronting the neglected problem of snake bite envenoming: the need for a global partnership, PLoS Med., 3, 10.1371/journal.pmed.0030150 · DOI · Paper page
- Gutiérrez, 2017, Preclinical evaluation of the efficacy of antivenoms for snakebite envenoming: state-of-the-art and challenges ahead, Toxins, 9, 163, 10.3390/toxins9050163 · DOI
- Gutiérrez, 2021, The search for natural and synthetic inhibitors that would complement antivenoms as therapeutics for snakebite envenoming, Toxins, 13, 451, 10.3390/toxins13070451 · DOI · Paper page
- Halilu, 2019, Snakebite burden in Sub-Saharan Africa: estimates from 41 countries, Toxicon, 159, 1, 10.1016/j.toxicon.2018.12.002 · DOI
- Harrison, 2019, The time is now: a call for action to translate recent momentum on tackling tropical snakebite into sustained benefit for victims, Trans. R. Soc. Trop. Med. Hyg., 113, 835, 10.1093/trstmh/try134 · DOI
- Howes, 2007, Neutralization of the haemorrhagic activities of viperine snake venoms and venom metalloproteinases using synthetic peptide inhibitors and chelators, Toxicon Off. J. Int. Soc. Toxinol., 49, 734, 10.1016/j.toxicon.2006.11.020 · DOI
- Kamiguti, 2000, Mass spectrophotometric evidence for P-III/P-IV metalloproteinases in the venom of the Boomslang (Dispholidus typus), Toxicon, 38, 1613, 10.1016/S0041-0101(00)00089-1 · doi:10.1016/s0041-0101(00)00089-1
- Kazandjian, 2021, Anticoagulant activity of Naja nigricollis venom is mediated by phospholipase A2 toxins and inhibited by varespladib, Toxins, 13, 302, 10.3390/toxins13050302 · DOI
- Kini, 2018, Biosynthetic Oligoclonal antivenom (BOA) for snakebite and next-generation treatments for snakebite victims, Toxins, 10, 534, 10.3390/toxins10120534 · DOI
- Knudsen, 2019, Engineering and design considerations for next-generation snakebite antivenoms, Toxicon Off. J. Int. Soc. Toxinol., 167, 67, 10.1016/j.toxicon.2019.06.005 · DOI
- Knudsen, 2020, Novel snakebite therapeutics must Be tested in appropriate rescue models to robustly assess their preclinical efficacy, Toxins, 12, 528, 10.3390/toxins12090528 · DOI
- Krüger, 2019, Fatal boomslang bite in the northern cape, Afr. J. Emerg. Med., 9, 53, 10.1016/j.afjem.2018.12.006 · doi:10.1016/j.afjem.2018.12.006
- Lakier, 1969, Consumptive coagulopathy caused by a boomslang bite, South Afr. Med. J. Suid-Afr Tydskr Vir Geneeskd., 43, 1052
- Layfield, 2020, Repurposing cancer drugs batimastat and marimastat to inhibit the activity of a group I metalloprotease from the venom of the western diamondback rattlesnake, Crotalus atrox. Toxins., 12, 309, 10.3390/toxins12050309 · DOI · Paper page
- Lewin, 2016, Varespladib (LY315920) appears to Be a potent, broad-spectrum, inhibitor of snake venom phospholipase A2 and a possible pre-referral treatment for envenomation, Toxins, 8, 248, 10.3390/toxins8090248 · DOI · Paper page
- Lewin, 2018, Delayed oral LY333013 rescues mice from highly neurotoxic, lethal doses of papuan Taipan (Oxyuranus scutellatus) venom, Toxins, 10, 380, 10.3390/toxins10100380 · DOI · Paper page
- Lewin, 2018, Delayed LY333013 (oral) and LY315920 (intravenous) reverse severe neurotoxicity and rescue Juvenile pigs from lethal doses of Micrurus fulvius (Eastern coral snake) venom, Toxins, 10, 10.3390/toxins10110479 · DOI · Paper page
- Liu, 2021, Snake venom proteome of Protobothrops mucrosquamatus in Taiwan: delaying venom-induced lethality in a rodent model by inhibition of phospholipase A2 activity with varespladib, J. Proteonomics, 234, 104084, 10.1016/j.jprot.2020.104084 · DOI
- Longbottom, 2018, Vulnerability to snakebite envenoming: a global mapping of hotspots, Lancet, 392, 673, 10.1016/S0140-6736(18)31224-8 · DOI · Paper page
- Matell, 1973, Consumption coagulopathy caused by a boomslang bite: a case report, Thromb. Res., 3, 173, 10.1016/0049-3848(73)90067-4 · doi:10.1016/0049-3848(73)90067-4
- Pla, 2017, What killed Karl Patterson Schmidt? Combined venom gland transcriptomic, venomic and antivenomic analysis of the South African green tree snake (the boomslang), Dispholidus typus, Biochim. Biophys. Acta Gen. Subj., 1861, 814, 10.1016/j.bbagen.2017.01.020 · DOI
- Potet, 2019, Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial, PLoS Negl. Trop. Dis., 13, 10.1371/journal.pntd.0007551 · DOI
- Rucavado A, Escalante T, Franceschi A, et al. Inhibition of local hemorrhage and dermonecrosis induced by Bothrops asper snake venom: effectiveness of early in situ administration of the peptidomimetic metalloproteinase inhibitor batimastat and the chelating agent CaNa EDTA. Am. J. Trop. Med. Hyg. 63. Published online 2000. · DOI · Paper page
- Sanhajariya, 2018, Pharmacokinetics of snake venom, Toxins, 10, 73, 10.3390/toxins10020073 · DOI · Paper page
- Seneci, 2021, A clot twist: extreme variation in coagulotoxicity mechanisms in Mexican neotropical rattlesnake venoms, Front. Immunol., 12, 612846, 10.3389/fimmu.2021.612846 · doi:10.3389/fimmu.2021.612846
- Slagboom, 2020, High throughput screening and identification of coagulopathic snake venom proteins and peptides using nanofractionation and proteomics approaches, PLoS Negl. Trop. Dis., 14, 10.1371/journal.pntd.0007802 · DOI
- Still, 2017, Multipurpose HTS coagulation analysis: assay development and assessment of coagulopathic snake venoms, Toxins, 9, 10.3390/toxins9120382 · DOI
- Wang, 2018, Exploration of the inhibitory potential of varespladib for snakebite envenomation, Molecules, 23, 391, 10.3390/molecules23020391 · DOI · Paper page
- Warrell, 1977, Poisoning by bites of the saw-scaled or carpet viper (Echis carinatus) in Nigeria, Q. J. Med., 46, 33
- Williams, 2019, The urgent need to develop novel strategies for the diagnosis and treatment of snakebites, Toxins, 11, 10.3390/toxins11060363 · DOI
- Xie, 2020, Neutralizing effects of small molecule inhibitors and metal chelators on coagulopathic Viperinae snake venom toxins, Biomedicines, 8, 297, 10.3390/biomedicines8090297 · DOI
- Xie, 2020, Neutralising effects of small molecule toxin inhibitors on nanofractionated coagulopathic Crotalinae snake venoms, Acta Pharm. Sin. B, 10, 1835, 10.1016/j.apsb.2020.09.005 · DOI · Paper page
- Youngman, 2020, Varespladib (LY315920) neutralises phospholipase A2 mediated prothrombinase-inhibition induced by Bitis snake venoms, Comp. Biochem. Physiol. C Toxicol. Pharmacol., 236, 108818, 10.1016/j.cbpc.2020.108818 · DOI
- Zietek, 2018, Liquid chromatographic nanofractionation with parallel mass spectrometric detection for the screening of plasmin inhibitors and (metallo)proteinases in snake venoms, Anal. Bioanal. Chem., 410, 5751, 10.1007/s00216-018-1253-x · DOI
Cited by
Hall, S. R., Rasmussen, S. A., Crittenden, E., Dawson, C. A., Bartlett, K. E., Westhorpe, A. P., Albulescu, L.-O., Kool, J., Gutiérrez, J. M., & Casewell, N. R. (2023) · Nature Communications · doi:10.1038/s41467-023-43510-w · Cited by 63
“These mechanistic variations likely underpin the previously described differences in SVMP-inhibiting potencies of these drugs in vitro 33,81,82 .”
Self-citationSmith, C. F., Modahl, C. M., Ceja Galindo, D., Larson, K. Y., Maroney, S. P., Bahrabadi, L., Brandehoff, N. P., Perry, B. W., McCabe, M. C., Petras, D., et al. (2024) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2024.100779 · Cited by 11
Investigating Snake-Venom-Induced Dermonecrosis and Inflammation Using an Ex Vivo Human Skin Model
Alsolaiss, J., Leeming, G., Da Silva, R., Alomran, N., Casewell, N. R., Habib, A. G., Harrison, R. A., & Modahl, C. M. (2024) · Toxins · doi:10.3390/toxins16060276 · Cited by 8
“Several in vitro assays [39–41] have been used to identify and assess venom toxins’ function and interaction with existing and promising snakebite therapies; these have included cell-based assays used Toxins 2024 , 16 , 276 3 of 23 to gain better insight into the tissue damage relevant to human…”
MethodSelf-citation
Metadata
- Authors
- Menzies, S. K., Clare, R. H., Xie, C., Westhorpe, A., Hall, S. R., Edge, R. J., Alsolaiss, J., Crittenden, E., Marriott, A. E., Harrison, R. A., Kool, J., & Casewell, N. R.
- ORCID
- Menzies, Stefanie K.
- Venue
- Toxicon: X
- Publisher
- Elsevier BV
- Published
- 2022-06
- Volume
- 14
- Pages
- 100118
- ISSN
- 2590-1710
- Cited by
- 46
- References
- 1
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Funders
- Liverpool School of Tropical Medicine
- China Scholarship Council (201706250035)
- Wellcome Trust (221712/Z/20/Z, 204806/Z/16/Z)
- The Royal Society
- Medical Research Council (MR/S00016X/1, 200517/Z/16/Z)
- Commonwealth Scholarship Commission
- University of Liverpool
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. https://app.cochat.ai/papers/10.1016/j.toxcx.2022.100118
- The paper
- Menzies, S. K., Clare, R. H., Xie, C., Westhorpe, A., Hall, S. R., Edge, R. J., Alsolaiss, J., Crittenden, E., Marriott, A. E., Harrison, R. A., Kool, J., & Casewell, N. R. (2022). In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus. Toxicon: X. https://doi.org/10.1016/j.toxcx.2022.100118
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.